Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert

Phase 1 Not yet recruiting 60 enrolled Daré Bioscience, Inc. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is looking for healthy female adults to use an vaginal ring with differing amounts of the hormone progesterone and go through a series of blood draws to measure how much progesterone is in the body following the use of these vaginal rings over an extended period of time.

Timeline

Start: 2026-09
Primary completion: 2027-11
Completion: 2028-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Progesterone	Other / unclassified	8 mg	Other
Subject	Progesterone	Other / unclassified	12 mg	Other
Subject	Progesterone	Other / unclassified	100 mg	Other

Indications

No indication recorded.